CAPR has been in the news 500% more than usual
Jul 11, 2025, 2:33 PM
13.87%
What does CAPR do
Capricor Therapeutics, based in Beverly Hills, develops biological therapies for serious medical conditions, focusing on CAP-1002 for Duchenne muscular dystrophy in Phase 3 trials. The company also utilizes exosome technology for various therapeutic applications.
CAPR has been in the news recently: Capricor Therapeutics Inc. (CAPR) experienced a decline in stock prices on Friday, despite a broader market trend where U.S. stock futures fell significantly. The company reported a 15% increase in revenue this quarter, attributed to strong demand for its new product line and strategic market expansion.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.